| Name | Blisibimod |
|---|
| Description | Blisibimod (A 623) is a potent and selective tetravalent inhibitor of B-cell activating factor (BAFF). Blisibimod can be used for the research of systemic lupus erythematosus (SLE)[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Blisibimod 以高亲和力阻断所有三种形式的 BAFF[1]。 |
| References |
| No Any Chemical & Physical Properties |